International Journal of Andrology · 2007 · 181 citations · 48 references
Life SciencesDevelopmental BiologyOncologyCancer GeneticsEndocrine OncologyNeoplasiaGenomic ImprintingGerm Cell DifferentiationGerm Cell MigrationGerm Cell TumorsMalignant NeoplasmsPrimordial Germ Cell DevelopmentGenomic Imprinting AnalysisGerm Cell Tumor PathogenesisHuman Embryonic Stem CellsPrimordial Germ Cell DifferentiationPrimordial Germ Cell OriginPrimordial Germ Cell ProliferationPrimordial Germ Cell SurvivalYolk Sac Tumors
Extragonadal germ cell tumours arise from germ cells that migrate along the body midline during development, with Type I and Type II tumours occurring in gonadal and extragonadal sites and developing in niches expressing stem‑cell factor and TSPY. The study reviews hypotheses on the origin and distribution of extragonadal GCTs and teratomas, incorporating recent advances in classification, genomic imprinting, and evidence that germ cells can arise from embryonic stem cells. Genomic imprinting data support a germ‑cell origin, and the more restricted distribution of Type II GCTs compared to Type I tumours reflects stricter survival and proliferation requirements of primordial germ cells/gonocytes.
Summary Hypotheses on the origin and distribution of extragonadal germ cell tumours (GCTs) and teratomas are briefly reviewed and revisited in the light of (i) new developments in the classification of GCTs, (ii) data on genomic imprinting of these neoplasms and (iii) the recent finding that germ cells can be derived from mouse and human embryonal stem (ES) cells. Only the Type I (infantile teratomas/yolk sac tumours) and Type II GCTs (seminomatous tumours and non‐seminomas) occur in the gonads and extragonadal localizations. The data on genomic imprinting lend support to the hypothesis that they are derived from germ cells. These precursor cells could have differentiated from ES cells in extragonadal localizations. Their distribution along the midline of the body is still best explained by the migration of primitive germ cells during development. The narrower distribution of the Type II than the Type I GCTs is probably due to the more strict conditions for survival and proliferation of primordial germ cells (PGCs)/gonocytes from which the Type II tumours originate, when compared with the precursor cells of Type I tumours, probably primitive germ cells closer to the ES cell. The known niches in which the Type II tumours develop have in common that they contain feeder cells expressing stem cell factor (SCF) – the ligand for the SCF receptor c‐KIT, involved in proliferation and survival of PGCs/gonocytes – and contain GBY including the gene TSPY.
48
Establishment in culture of pluripotential cells from mouse embryos
Martin Evans, M. H. Kaufman · Nature · 1981 · 8.6K citations
Parental imprinting of the mouse H19 gene
Marisa S. Bartolomei, Sharon Zemel, Shirley M. Tilghman · Nature · 1991 · 1.2K citations
Derivation of Oocytes from Mouse Embryonic Stem Cells
Karin Hübner, Guy Fuhrmann, Lane K. Christenson et al. · Science · 2003 · 1.1K citations